Zobrazeno 1 - 10
of 35
pro vyhledávání: '"David Voduc"'
Autor:
Obi L. Griffith, Nicholas C. Spies, Meenakshi Anurag, Malachi Griffith, Jingqin Luo, Dongsheng Tu, Belinda Yeo, Jason Kunisaki, Christopher A Miller, Kilannin Krysiak, Jasreet Hundal, Benjamin J Ainscough, Zachary L. Skidmore, Katie Campbell, Runjun Kumar, Catrina Fronick, Lisa Cook, Jacqueline E. Snider, Sherri Davies, Shyam M. Kavuri, Eric C. Chang, Vincent Magrini, David E. Larson, Robert S Fulton, Shuzhen Liu, Samuel Leung, David Voduc, Ron Bose, Mitch Dowsett, Richard K. Wilson, Torsten O. Nielsen, Elaine R Mardis, Matthew J. Ellis
Publikováno v:
Nature Communications, Vol 9, Iss 1, Pp 1-16 (2018)
Unravelling the link between somatic mutation and prognosis in estrogen positive (ER+) breast cancer requires the use of long-term follow-up data. Here, combining archival formalin-fixed paraffin embedded tissue and targeted sequencing in three cohor
Externí odkaz:
https://doaj.org/article/fe27abc720eb4d50bc7f128d4b6ad490
Autor:
Obi L. Griffith, Nicholas C. Spies, Meenakshi Anurag, Malachi Griffith, Jingqin Luo, Dongsheng Tu, Belinda Yeo, Jason Kunisaki, Christopher A Miller, Kilannin Krysiak, Jasreet Hundal, Benjamin J Ainscough, Zachary L. Skidmore, Katie Campbell, Runjun Kumar, Catrina Fronick, Lisa Cook, Jacqueline E. Snider, Sherri Davies, Shyam M. Kavuri, Eric C. Chang, Vincent Magrini, David E. Larson, Robert S Fulton, Shuzhen Liu, Samuel Leung, David Voduc, Ron Bose, Mitch Dowsett, Richard K. Wilson, Torsten O. Nielsen, Elaine R Mardis, Matthew J. Ellis
Publikováno v:
Nature Communications, Vol 9, Iss 1, Pp 1-2 (2018)
The original version of this Article contained errors in the depiction of confidence intervals in the NF1 BCSS data illustrated in Figure 3b. These have now been corrected in both the PDF and HTML versions of the Article. The incorrect version of Fig
Externí odkaz:
https://doaj.org/article/e0785765fab94e23801e3e65819e240a
Autor:
Torsten O. Nielsen, Charles M. Perou, Philip S. Bernard, Matthew J. Ellis, Joel S. Parker, Mark T.W. Ebbert, Carole Davis, Inge J. Stijleman, Sherri Davies, Kathleen I. Pritchard, Mark N. Levine, Lois E. Shepherd, Stephen K. Chia, Samuel Leung, Shan Jiang, Dongsheng Tu, K. David Voduc, Maggie C.U. Cheang
PDF file - 44K
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0bdef29a39de8ebccd33401bfe5e6092
https://doi.org/10.1158/1078-0432.22443840
https://doi.org/10.1158/1078-0432.22443840
Autor:
Torsten O. Nielsen, Charles M. Perou, Philip S. Bernard, Matthew J. Ellis, Joel S. Parker, Mark T.W. Ebbert, Carole Davis, Inge J. Stijleman, Sherri Davies, Kathleen I. Pritchard, Mark N. Levine, Lois E. Shepherd, Stephen K. Chia, Samuel Leung, Shan Jiang, Dongsheng Tu, K. David Voduc, Maggie C.U. Cheang
PDF file - 49K
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a6523fcc0f7ce1bf27d4468d2022c36
https://doi.org/10.1158/1078-0432.22443843
https://doi.org/10.1158/1078-0432.22443843
Autor:
Matthew J. Ellis, Philip S. Bernard, Charles M. Perou, Elaine R. Mardis, Maggie C.U. Cheang, Jerry Reed, Inge J. Stijleman, Jacqueline Snider, Sherri R. Davies, Tammi Vickery, Mark Ebbert, David Voduc, Samuel Leung, Joel S. Parker, Torsten O. Nielsen
Supplementary Data from A Comparison of PAM50 Intrinsic Subtyping with Immunohistochemistry and Clinical Prognostic Factors in Tamoxifen-Treated Estrogen Receptor–Positive Breast Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a123b9db0d98568e7868608d025d44a
https://doi.org/10.1158/1078-0432.22442727
https://doi.org/10.1158/1078-0432.22442727
Autor:
Torsten O. Nielsen, Charles M. Perou, Philip S. Bernard, Matthew J. Ellis, Joel S. Parker, Mark T.W. Ebbert, Carole Davis, Inge J. Stijleman, Sherri Davies, Kathleen I. Pritchard, Mark N. Levine, Lois E. Shepherd, Stephen K. Chia, Samuel Leung, Shan Jiang, Dongsheng Tu, K. David Voduc, Maggie C.U. Cheang
PDF file - 136K
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::445c172bfe33709fc97b95eb3d162f54
https://doi.org/10.1158/1078-0432.22443849.v1
https://doi.org/10.1158/1078-0432.22443849.v1
Autor:
Torsten O. Nielsen, Charles M. Perou, Philip S. Bernard, Matthew J. Ellis, Joel S. Parker, Mark T.W. Ebbert, Carole Davis, Inge J. Stijleman, Sherri Davies, Kathleen I. Pritchard, Mark N. Levine, Lois E. Shepherd, Stephen K. Chia, Samuel Leung, Shan Jiang, Dongsheng Tu, K. David Voduc, Maggie C.U. Cheang
Purpose: Recent studies suggest that intrinsic breast cancer subtypes may differ in their responsiveness to specific chemotherapy regimens. We examined this hypothesis on NCIC.CTG MA.5, a clinical trial randomizing premenopausal women with node-posit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::506647689b36aace0b7b46c9d5bbae0b
https://doi.org/10.1158/1078-0432.c.6519981
https://doi.org/10.1158/1078-0432.c.6519981
Autor:
Matthew J. Ellis, Philip S. Bernard, Charles M. Perou, Elaine R. Mardis, Maggie C.U. Cheang, Jerry Reed, Inge J. Stijleman, Jacqueline Snider, Sherri R. Davies, Tammi Vickery, Mark Ebbert, David Voduc, Samuel Leung, Joel S. Parker, Torsten O. Nielsen
Purpose: To compare clinical, immunohistochemical (IHC), and gene expression models of prognosis applicable to formalin-fixed, paraffin-embedded blocks in a large series of estrogen receptor (ER)–positive breast cancers from patients uniformly trea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5eed00fc8ac8b34649c8237362f811f1
https://doi.org/10.1158/1078-0432.c.6519396
https://doi.org/10.1158/1078-0432.c.6519396
Autor:
Torsten O. Nielsen, Charles M. Perou, Philip S. Bernard, Matthew J. Ellis, Joel S. Parker, Mark T.W. Ebbert, Carole Davis, Inge J. Stijleman, Sherri Davies, Kathleen I. Pritchard, Mark N. Levine, Lois E. Shepherd, Stephen K. Chia, Samuel Leung, Shan Jiang, Dongsheng Tu, K. David Voduc, Maggie C.U. Cheang
PDF file - 270K
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a3d188c42c92e905640374ee1c4c5c7
https://doi.org/10.1158/1078-0432.22443846.v1
https://doi.org/10.1158/1078-0432.22443846.v1
Autor:
Timothy Joseph Whelan, Sally Smith, Torsten O. Nielsen, Sameer Parpia, Anthony W. Fyles, Anita Bane, Fei-Fei Liu, Laval Grimard, Christiaan Stevens, Julie Bowen, Sawyna Provencher, Eileen Rakovitch, Valerie Theberge, Anna Marie Mulligan, Mohamed A. Akra, K. David Voduc, Tarek Hijal, Ian S. Dayes, Gregory Russell Pond, Mark Norman Levine
Publikováno v:
Journal of Clinical Oncology. 40:LBA501-LBA501
LBA501 Background: Adjuvant breast RT is usually prescribed following BCS to reduce the risk of local recurrence (LR). However, this treatment is inconvenient, costly, and associated with acute and late toxicity. Traditional clinical pathological fac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9a41598561d0f78866035703f9f89611
https://doi.org/10.1200/jco.2022.40.17_suppl.lba501
https://doi.org/10.1200/jco.2022.40.17_suppl.lba501